US Patent 11426413 Oral liquid compositions including chlorpromazine
Patent 11426413 was granted and assigned to Genus Lifesciences Inc. on August, 2022 by the United States Patent and Trademark Office.
All edits
Edits on 16 Oct, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Suhas Gumaste0
Vaishnavi Parikh0
Edits on 27 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 31 Aug, 2022
Golden AI
Edits made to:
Infobox (+10 properties)
Article (+186 characters)
US Patent 11426413 Oral liquid compositions including chlorpromazine
Article
Stable oral liquid compositions including chlorpromazine or a pharmaceutically acceptable salt or solvate of chlorpromazine, and methods of administering the compositions, are disclosed.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
11426413
Date of Patent
August 30, 2022
Patent Application Number
17314427
Date Filed
May 7, 2021
Patent Primary Examiner
CPC Code
Find more entities like US Patent 11426413 Oral liquid compositions including chlorpromazine
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.